Acadia Healthcare Company, Inc. $ACHC Shares Sold by Integral Health Asset Management LLC

Key Points

• Integral Health Asset Management reduced its stake in Acadia Healthcare by 25%, selling 100,000 shares and leaving it with 300,000 shares worth about $7.43 million (0.33% ownership).
• Analysts are mixed: recent price-target moves range from cuts to raises, the consensus rating is "Hold" with an average price target of $21.15.
• Acadia beat the quarter on both EPS ($0.07 vs. $0.03 est.) and revenue ($821.46M vs. $800.10M), set FY2026 guidance of $1.30–$1.55 EPS, but Zacks has cut multiple near-term and multi-year EPS estimates, tempering expectations.

Integral Health Asset Management LLC decreased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 25.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 300,000 shares of the company's stock after selling 100,000 shares during the period. Integral Health Asset Management LLC owned 0.33% of Acadia Healthcare worth $7,428,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ACHC. Principal Financial Group Inc. boosted its position in shares of Acadia Healthcare by 112.1% during the third quarter. Principal Financial Group Inc. now owns 442,943 shares of the company's stock worth $10,967,000 after buying an additional 234,107 shares during the period. Vanguard Group Inc. raised its stake in Acadia Healthcare by 7.8% during the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company's stock valued at $233,166,000 after acquiring an additional 681,278 shares in the last quarter. First Citizens Bank & Trust Co. boosted its position in Acadia Healthcare by 164.1% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company's stock worth $1,464,000 after acquiring an additional 36,733 shares during the period. Public Sector Pension Investment Board bought a new position in shares of Acadia Healthcare in the third quarter worth $8,919,000. Finally, Caxton Associates LLP increased its holdings in shares of Acadia Healthcare by 1,234.5% during the second quarter. Caxton Associates LLP now owns 173,482 shares of the company's stock valued at $3,936,000 after purchasing an additional 160,482 shares during the period.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. KeyCorp reduced their price objective on shares of Acadia Healthcare from $30.00 to $25.00 and set an "overweight" rating for the company in a report on Wednesday, December 3rd. Leerink Partners boosted their price target on shares of Acadia Healthcare from $14.00 to $22.00 and gave the stock a "market perform" rating in a research report on Thursday, February 26th. Cantor Fitzgerald set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Finally, Barclays boosted their target price on Acadia Healthcare from $14.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 3rd. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $21.15.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $23.52 on Friday. The company has a 50-day moving average of $16.80 and a 200-day moving average of $18.78. The firm has a market cap of $2.17 billion, a price-to-earnings ratio of -1.93, a price-to-earnings-growth ratio of 8.16 and a beta of 0.74. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $31.04.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.04. The company had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company's quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Key Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia added Daniel Cancelmi to its Board of Directors, a governance move that can be viewed positively as expanding board expertise and oversight. Article Title
• Neutral Sentiment: Reported short-interest data shows zero shares and days-to-cover of 0.0 — the release appears to contain anomalous or missing data (NaN/0) and therefore provides no clear signal about bearish positioning.
• Negative Sentiment: Zacks Research cut multiple near-term and multi-year EPS estimates and keeps a "Hold" rating. Key changes include Q2 2026 EPS cut to $0.49 (from $0.66), FY2026 to $1.48 (from $1.85), and FY2027 to $1.55 (from $1.96), plus several quarter-by-quarter reductions across 2026–2027. These downward revisions lower investor expectations and are the main reason for today’s downward pressure on the stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.